Christopher Ryan Sullivan - Chief Financial Officer at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
AVTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Ryan Sullivan since 10/25/2024

Holdings reported by Christopher Ryan Sullivan for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 48.4K $409K $8.46 Mar 28, 2025 Direct Common Stock
Common Stock 16.9K $143K $8.46 Mar 28, 2025 Direct
Stock Option (Right to Buy) 163K Jan 28, 2025 Direct Common Stock

Transactions reported by Christopher Ryan Sullivan for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.